HIV Is No Longer a Death Sentence—But Doctors Say These Myths Still Put Lives at Risk

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...
ScienceAlert on MSN

HIV's Cunning Strategy For Hiding in Our Body Finally Revealed

According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

South Africa’s health minister hails new HIV prevention jab but warns of limited supply

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

HIV's shape-shifting protein reveals clues for smarter drug design

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

South Africa welcomes $115M US bridge plan to sustain its HIV programs for 6 months

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...

A breakthrough to prevent HIV shouldn’t break the bank

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...
Medscape

Study: Rate of Dermatologic Disease in HIV Plunges, but Some Groups Remain Vulnerable

A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...
Georgia Recorder

HIV rates are highest in the American South, despite effective treatments

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...
Medscape

Shingles Vaccination Linked to Vascular Benefits With Breakthrough Infections and in People With HIV

Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...

HIV prevention jab approved for use in England and Wales. Here's how it works

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Jharkhand: 5 thalassemia-affected children test HIV positive after blood transfusion; 3 officials suspended, probe ordered

Five children in Chaibasa, Jharkhand, contracted HIV after receiving infected blood during transfusions. The state government ...